Clotting Factors to Treat Thrombolysis Related Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke

BACKGROUND: Symptomatic intracranial hemorrhage (sICH) occurs uncommonly after ischemic stroke therapy with Tissue plasminogen activator (TPA). Clotting factor administration may be a treatment option. OBJECTIVE: To determine if treatment with clotting factors was associated with improved outcomes i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Alderazi, Yazan J, Barot, Nirav Kumar V., Peng, Hui, Vahidy, Farhaan S., Navalkele, Digvijaya D, Sangha, Navdeep, Misra, Vivek, Savitz, Sean I.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3959230/
https://ncbi.nlm.nih.gov/pubmed/24321775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky